ATG9B and colorectal carcinoma: Mechanistically, ATG9B interacts with MYH9 and promotes integrin β1 activation, leading to accelerated focal adhesion (FA) assembly and promoting CRC invasion and metastasis primarily through autophagy-independent mechanisms [74].